- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03587909
FLACS vs Phaco in Shallow Anterior Chamber
Intraoperative Performance and Postoperative Outcomes Following Femtosecond Laser Assisted Cataract Surgery (FLACS) and Manual Phacoemulsification in Eyes With Shallow Anterior Chamber
Phacoemulsification in eyes with a shallow anterior chamber (ACD < 2.2mm) presents with problems of safe access to the cataract and increased vulnerability of the endothelium and a higher tendency of complications such as descemet's detachment and iris prolapse. A shallow anterior chamber is also responsible for the high incidence of glaucoma and postoperative complications after cataract surgery. Femtosecond assisted cataract surgery has made cataract surgery safer and more predictable. The effective phacoemulsification time and intra-operative manipulation is greatly reduced in FLACS. However phacoemulsification still remains the most widely performed cataract surgery around the world. Post-operative outcomes after phacoemulsification in patients having shallow anterior chamber have been extensively reported in literature over the years.
There is no head to head comparison in terms of intraoperative performance and post-operative outcomes between FLACS and phacoemulsification in eyes with shallow anterior chamber.
The aim is to compare the intra-operative performance and post-operative outcomes in eyes undergoing femtosecond laser assisted cataract surgery versus eyes undergoing phacoemulsification in eyes having shallow anterior chamber.
The study will bring an understanding on the question: Do patients undergoing Femtosecond laser assisted cataract surgery behave differently from those undergoing phacoemulsification?
Study Overview
Status
Intervention / Treatment
Detailed Description
Inclusion Criteria:
- Age-related cataract
- Shallow Anterior Chamber (<2.5mm)
Exclusion Criteria:
-Ocular co-morbidity - corneal disorders, glaucoma, uveitis, previous ocular surgery
Surgical Technique :
- Standardized, Single Surgeon
- 2.2 mm clear corneal temporal incision
- FLACS Group : Capsulorhexis, Lens Fragmentation with femto laser
The investigators will be evaluating the following parameters:
- Primary outcome measure Corneal thickness on day 1, week 1 and 1 month (Change in corneal thickness of 15% from preop. will be considered significant).
Secondary outcome measures
- Corneal clarity -on day 1, week 1 and 1 month postoperatively
- Anterior chamber cells and flare (Hogan's criteria)
- Percentage change in endothelial cell density from preoperatively to 3 months postoperatively
- Unaided visual acuity (distance) on day 1 and 1 month.
- Best corrected distance visual acuity 1 month postoperatively
- Other Observations :
1) Cumulative Dissipated Energy (CDE) 2) Surgical time 3) Fluid used 4) Descemets membrane detachment during surgery 5) Incidence of iris trauma 6) Any other intra-operative complications
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gujarat
-
Ahmedabad, Gujarat, India, 380052
- Iladevi Cataract & IOL Research Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- uncomplicated, age related cataracts
- Shallow anterior chamber (measured as </=2.5mm )
Exclusion Criteria:
- Coexisting ocular morbidity,
- inability to come for followup
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Phacoemulsification Cataract Surgery
Procedure / Surgery : Phacoemulsification Surgery
|
Phacoemulsification in eyes with shallow anterior chamber (<2.5mm depth)
|
Active Comparator: Femtosecond Cataract Surgery
Procedure / SUrgery - Femtosecond Laser Cataract surgery
|
Femtosecond Cataract Surgery in eyes with shallow anterior chamber < 2.5mm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Central Corneal Thickness
Time Frame: Postoperative Day 1
|
Central Corneal Thickness
|
Postoperative Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anterior Chamber Inflammation
Time Frame: Postoperative Day 1
|
Anterior chamber cells and flare (Hogan's criteria)
|
Postoperative Day 1
|
Endothelial Cell Morphology
Time Frame: Postoperative 6 months
|
Endothelial Cell Density
|
Postoperative 6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Abhay Vasavada, MS,FRCS, Iladevi Cataract & IOL Research Centre, Ahmedabad
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FLACS1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract Surgery
-
National University Hospital, SingaporeSingapore General HospitalCompletedCataract Surgery | Stress Levels | Music Improving Outcomes in Cataract SurgerySingapore
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
Advanced Center for Eyecare GlobalNot yet recruiting
-
Johannes Kepler University of LinzCompletedCataract SurgeryAustria
-
Research Insight LLCCompleted
-
University of British ColumbiaUnknownCataract SurgeryGhana
-
Innovative MedicalCompleted
-
Carl Zeiss Meditec, Inc.Enrolling by invitation
-
Ilasis LaserCompletedCataract SurgeryFrance
-
PeriPharmImprimis Pharmaceuticals, Inc.; Advance Dosage Forms, Inc.TerminatedCataract SurgeryCanada
Clinical Trials on Phacoemulsification Cataract SUrgery
-
Federal University of São PauloCompletedCataract | PseudophakiaBrazil
-
Centro Hospitalar do Baixo VougaCompleted
-
Iladevi Cataract and IOL Research CenterCompleted
-
Glaukos CorporationCompletedOpen-Angle GlaucomaUnited States
-
Centre Hospitalier Régional Metz-ThionvilleCompletedCataract | Endothelial Cell Loss, Corneal | PhacoemulsificationFrance
-
Guy's and St Thomas' NHS Foundation TrustCompletedCataract | Surgery
-
University Hospital, BordeauxCompleted
-
Iladevi Cataract and IOL Research CenterCompletedQuality of Life | Visual OutcomesIndia
-
University of Turin, ItalyCompleted